Healthy Smokers
10
0
0
8
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
10.0%
1 terminated out of 10 trials
88.9%
+2.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (10)
Biomarkers of iNOS Activity in COPD, Asthma, Healthy Control
Effect Of Deep Breathing Exercises In Smokers
Nicotine Patch - Bioequivalence Study
Efficacy and Safety of an Electronic Nicotine Delivery Device (E-Cigarette) Without Nicotine Cartridges
Efficacy and Safety of an Electronic Nicotine Delivery Device (E-Cigarette)
A Structured Protocol to Evaluate Efficacy and Safety of a Popular Electronic Nicotine Delivery Device (E-Cigarette) Efficacy and Safety of a Popular Electronic Nicotine Delivery Device (E-Cigarette)
Nicotine Patch - Multidose Bioequivalence Study
Nicotine Patch Bioequivalence Study
Pilot Pharmacokinetic Study of New Nicotine Lozenge Formulations
Range of Neutrophil Response to 20,000 EU of Clinical Center Reference Endotoxin in Otherwise Healthy Smokers